Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Equity Ratio (2016 - 2026)

Pharma-Bio Serv filings provide 16 years of Equity Ratio readings, the most recent being 0.76 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 1.28% to 0.76 in Q1 2026 year-over-year; TTM through Jan 2026 was 0.76, a 1.28% increase, with the full-year FY2025 number at 0.87, up 3.66% from a year prior.
  • Equity Ratio hit 0.76 in Q1 2026 for Pharma-Bio Serv, down from 0.87 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.88 in Q3 2025 to a low of 0.74 in Q1 2024.
  • Median Equity Ratio over the past 5 years was 0.8 (2023), compared with a mean of 0.81.
  • Biggest five-year swings in Equity Ratio: increased 11.99% in 2022 and later dropped 6.04% in 2023.
  • Pharma-Bio Serv's Equity Ratio stood at 0.8 in 2022, then grew by 1.06% to 0.81 in 2023, then rose by 3.89% to 0.84 in 2024, then increased by 3.66% to 0.87 in 2025, then fell by 13.4% to 0.76 in 2026.
  • The last three reported values for Equity Ratio were 0.76 (Q1 2026), 0.87 (Q4 2025), and 0.88 (Q3 2025) per Business Quant data.